Literature DB >> 28836619

Beyond gut feelings: how the gut microbiota regulates blood pressure.

Francine Z Marques1,2, Charles R Mackay3, David M Kaye1,4,5.   

Abstract

Hypertension is the leading risk factor for heart disease and stroke, and is estimated to cause 9.4 million deaths globally every year. The pathogenesis of hypertension is complex, but lifestyle factors such as diet are important contributors to the disease. High dietary intake of fruit and vegetables is associated with reduced blood pressure and lower cardiovascular mortality. A critical relationship between dietary intake and the composition of the gut microbiota has been described in the literature, and a growing body of evidence supports the role of the gut microbiota in the regulation of blood pressure. In this Review, we describe the mechanisms by which the gut microbiota and its metabolites, including short-chain fatty acids, trimethylamine N-oxide, and lipopolysaccharides, act on downstream cellular targets to prevent or contribute to the pathogenesis of hypertension. These effects have a direct influence on tissues such as the kidney, the endothelium, and the heart. Finally, we consider the role of the gut microbiota in resistant hypertension, the possible intergenerational effect of the gut microbiota on blood pressure regulation, and the promising therapeutic potential of gut microbiota modification to improve health and prevent disease.

Entities:  

Mesh:

Year:  2017        PMID: 28836619     DOI: 10.1038/nrcardio.2017.120

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  145 in total

1.  Gut dysbiosis is linked to hypertension.

Authors:  Tao Yang; Monica M Santisteban; Vermali Rodriguez; Eric Li; Niousha Ahmari; Jessica Marulanda Carvajal; Mojgan Zadeh; Minghao Gong; Yanfei Qi; Jasenka Zubcevic; Bikash Sahay; Carl J Pepine; Mohan K Raizada; Mansour Mohamadzadeh
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

2.  Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats.

Authors:  M Sipola; P Finckenberg; J Santisteban; R Korpela; H Vapaatalo; M L Nurminen
Journal:  J Physiol Pharmacol       Date:  2001-12       Impact factor: 3.011

3.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

Authors:  Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel.

Authors:  Kiyoshi Nakagawa; Vijaykumar R Holla; Yuan Wei; Wen-Hui Wang; Arnaldo Gatica; Shouzou Wei; Shaojun Mei; Crystal M Miller; Dae Ryong Cha; Edward Price; Roy Zent; Ambra Pozzi; Matthew D Breyer; Youfei Guan; John R Falck; Michael R Waterman; Jorge H Capdevila
Journal:  J Clin Invest       Date:  2006-05-11       Impact factor: 14.808

5.  Human genetics shape the gut microbiome.

Authors:  Julia K Goodrich; Jillian L Waters; Angela C Poole; Jessica L Sutter; Omry Koren; Ran Blekhman; Michelle Beaumont; William Van Treuren; Rob Knight; Jordana T Bell; Timothy D Spector; Andrew G Clark; Ruth E Ley
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

6.  Acetate relaxation of isolated vascular smooth muscle.

Authors:  J T Daugirdas; Z M Nawab
Journal:  Kidney Int       Date:  1987-07       Impact factor: 10.612

7.  Gut Microbiome Associates With Lifetime Cardiovascular Disease Risk Profile Among Bogalusa Heart Study Participants.

Authors:  Tanika N Kelly; Lydia A Bazzano; Nadim J Ajami; Hua He; Jinying Zhao; Joseph F Petrosino; Adolfo Correa; Jiang He
Journal:  Circ Res       Date:  2016-08-09       Impact factor: 17.367

8.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

9.  Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.

Authors:  Benoit Chassaing; Omry Koren; Julia K Goodrich; Angela C Poole; Shanthi Srinivasan; Ruth E Ley; Andrew T Gewirtz
Journal:  Nature       Date:  2015-02-25       Impact factor: 49.962

10.  Revised Estimates for the Number of Human and Bacteria Cells in the Body.

Authors:  Ron Sender; Shai Fuchs; Ron Milo
Journal:  PLoS Biol       Date:  2016-08-19       Impact factor: 8.029

View more
  93 in total

Review 1.  Influence of dietary protein on Dahl salt-sensitive hypertension: a potential role for gut microbiota.

Authors:  Justine M Abais-Battad; David L Mattson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-22       Impact factor: 3.619

2.  Gastrointestinal sodium absorption, microbiome, and hypertension.

Authors:  Ricardo S Mishima; Adrian D Elliott; Prashanthan Sanders; Dominik Linz
Journal:  Nat Rev Cardiol       Date:  2017-10-13       Impact factor: 32.419

Review 3.  Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management.

Authors:  Alexandra Jichitu; Simona Bungau; Ana Maria Alexandra Stanescu; Cosmin Mihai Vesa; Mirela Marioara Toma; Cristiana Bustea; Stela Iurciuc; Marius Rus; Nicolae Bacalbasa; Camelia Cristina Diaconu
Journal:  Diagnostics (Basel)       Date:  2021-04-12

Review 4.  Microbiota in cerebrovascular disease: A key player and future therapeutic target.

Authors:  Shuichi Tonomura; Masafumi Ihara; Robert P Friedland
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-20       Impact factor: 6.200

5.  Prebiotic supplementation modulates advanced glycation end-products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized-controlled clinical trial.

Authors:  Mahdieh Abbasalizad Farhangi; Parvin Dehghan; Nazli Namazi
Journal:  Eur J Nutr       Date:  2019-11-14       Impact factor: 5.614

6.  Gut Microbiome and Response to Cardiovascular Drugs.

Authors:  Sony Tuteja; Jane F Ferguson
Journal:  Circ Genom Precis Med       Date:  2019-08-28

Review 7.  Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.

Authors:  Panayiotis Louca; Cristina Menni; Sandosh Padmanabhan
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

8.  Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation.

Authors:  Gregory J Weber; Jaleyea Foster; Sathnur B Pushpakumar; Utpal Sen
Journal:  Pharmacol Res       Date:  2018-06-15       Impact factor: 7.658

Review 9.  Low birth weight trends: possible impacts on the prevalences of hypertension and chronic kidney disease.

Authors:  Takeshi Kanda; Ayano Murai-Takeda; Hiroshi Kawabe; Hiroshi Itoh
Journal:  Hypertens Res       Date:  2020-05-11       Impact factor: 3.872

Review 10.  Gut microbiome production of short-chain fatty acids and obesity in children.

Authors:  Selvasankar Murugesan; Khemlal Nirmalkar; Carlos Hoyo-Vadillo; Matilde García-Espitia; Daniela Ramírez-Sánchez; Jaime García-Mena
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.